Aarkstore - Myungmoon pharmaceutical Co.,Ltd. - Product Pipeline Review - 2014 - PowerPoint PPT Presentation

Loading...

PPT – Aarkstore - Myungmoon pharmaceutical Co.,Ltd. - Product Pipeline Review - 2014 PowerPoint presentation | free to download - id: 6cd74f-Y2YwO



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Aarkstore - Myungmoon pharmaceutical Co.,Ltd. - Product Pipeline Review - 2014

Description:

"GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014"report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. – PowerPoint PPT presentation

Number of Views:13

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Aarkstore - Myungmoon pharmaceutical Co.,Ltd. - Product Pipeline Review - 2014


1
Myungmoon pharmaceutical Co.,Ltd. - Product
Pipeline Review - 2014
Category Pharmaceuticals Healthcare
  • Browse Complete Report -
  • http//www.aarkstore.com/pharmaceuticals-healthcar
    e/63686/myungmoon-pharmaceutical-coltd-product-pip
    eline-review

2
Myungmoon pharmaceutical Co.,Ltd. - Product
Pipeline Review - 2014
3
Summary
  • Global Markets Directs, Myungmoon
    pharmaceutical Co.,Ltd. - Product Pipeline Review
    - 2014, provides an overview of the Myungmoon
    pharmaceutical Co.,Ltd.s pharmaceutical research
    and development focus.This report provides
    comprehensive information on the current
    therapeutic developmental pipeline of Myungmoon
    pharmaceutical Co.,Ltd.s, complete with
    comparative analysis at various stages,
    therapeutics assessment by drug target, mechanism
    of action (MoA), route of administration (RoA)
    and molecule type. It also reviews latest
    updates, and featured news and press releases,
    along with special features on late-stage and
    discontinued projects. Myungmoon pharmaceutical
    Co.,Ltd. - Product Pipeline Review - 2014"report
    features investigational drugs from across globe
    covering over 20 therapy areas and nearly 3,000
    indications. The report is built using data and
    information sourced from Global Markets Directs
    proprietary databases, Company/University
    websites, SEC filings, investor presentations and
    featured press releases from company/university
    sites and industry-specific third party sources,
    put together by Global Markets Directs team.

4
Summary
  • Drug profiles/records featured in the report
    undergoes periodic updation following a stringent
    set of processes that ensures that all the
    profiles are updated with the latest set of
    information. Additionally, processes including
    live news deals tracking, browser based
    alert-box and clinical trials registries tracking
    ensure that the most recent developments are
    captured on a real time basis.  The report
    enhances decision making capabilities and help to
    create effective counter strategies to gain
    competitive advantage. It strengthens RD
    pipelines by identifying new targets and MOAs to
    produce first-in-class and best-in-class
    products.  Note Certain sections in the
    report may be removed or altered based on the
    availability and relevance of data for the
    indicated disease. 

5
Scope
  • - The report provides brief overview of Myungmoon
    pharmaceutical Co.,Ltd. including business
    description, key information and facts, and its
    locations and subsidiaries - The report reviews
    current pipeline of Myungmoon pharmaceutical
    Co.,Ltd.s human therapeutic division and enlists
    all their major and minor projects - The report
    features product description and descriptive
    mechanism of action for key pipeline products
    along with the products developmental history
    and major milestones  - Special feature on
    out-licensed and partnered product portfolio -
    The report summarizes all the dormant and
    discontinued pipeline projects - Latest company
    statement  - Latest news and deals relating to
    the Myungmoon pharmaceutical Co.,Ltd.s pipeline
    products

6
Reasons to buy
  • - Evaluate Myungmoon pharmaceutical Co.,Ltd.s
    strategic position with total access to detailed
    information on its product pipeline - Assess the
    growth potential of Myungmoon pharmaceutical
    Co.,Ltd. in its therapy areas of focus -
    Identify new drug targets and therapeutic classes
    in the Myungmoon pharmaceutical Co.,Ltd.s RD
    portfolio and develop key strategic initiatives
    to reinforce pipeline in those areas - Exploit
    in-licensing opportunities by identifying windows
    of opportunity to fill portfolio gaps - Develop
    strategic initiatives by understanding the focus
    areas of Myungmoon pharmaceutical Co.,Ltd. and
    exploit collaboration and partnership
    opportunities - Identify emerging players with
    potentially strong product portfolio and create
    effective counter-strategies to gain competitive
    advantage - Plan mergers and acquisitions
    effectively by identifying the most promising
    pipeline of Myungmoon pharmaceutical Co.,Ltd. -
    Develop and design in-licensing and out-licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and scope   

7
Table of Content
List of Tables 3List of Figures 3Myungmoon
pharmaceutical Co.,Ltd. Snapshot 4Myungmoon
pharmaceutical Co., Ltd. Overview 4Key
Information 4Key Facts 4Myungmoon
pharmaceutical Co., Ltd. - Research and
Development Overview 5Key Therapeutic Areas
5Myungmoon pharmaceutical Co., Ltd. - Pipeline
Review 7Pipeline Products by Stage of
Development 7Pipeline Products - Monotherapy
8Myungmoon pharmaceutical Co.,Ltd. - Pipeline
Products Glance 9Myungmoon pharmaceutical
Co.,Ltd. - Early Stage Pipeline Products
9Discovery Products/Combination Treatment
Modalities 9
8
Table of Content
Myungmoon pharmaceutical Co.,Ltd. - Drug Profiles
10MM-A01-01 10Product Description 10Mechanism
of Action 10RD Progress 10MM-P01-01 11Product
Description 11Mechanism of Action 11RD
Progress 11MM-P01-02 12Product Description
12Mechanism of Action 12RD Progress
12MM-P02-01 13Product Description 13Mechanism
of Action 13RD Progress 13
9
List Of Tables
  • Myungmoon pharmaceutical Co.,Ltd., Key
    Information 4Myungmoon pharmaceutical Co.,Ltd.,
    Key Facts 4Myungmoon pharmaceutical Co.,Ltd. -
    Pipeline by Indication, 2014 6Myungmoon
    pharmaceutical Co.,Ltd. - Pipeline by Stage of
    Development, 2014 7Myungmoon pharmaceutical
    Co.,Ltd. - Monotherapy Products in Pipeline, 2014
    8Myungmoon pharmaceutical Co.,Ltd. - Discovery,
    2014 9Myungmoon pharmaceutical Co.,Ltd. -
    Pipeline by Target, 2014 14Myungmoon
    pharmaceutical Co.,Ltd. - Pipeline by Molecule
    Type, 2014 15Myungmoon pharmaceutical Co.,Ltd. -
    Pipeline Products by Mechanism of Action, 2014
    16Myungmoon pharmaceutical Co.,Ltd., Other
    Locations 17   

10
List of Figures
  • Myungmoon pharmaceutical Co.,Ltd. - Pipeline by
    Top 10 Indication, 2014 6

11
Related Reports
  • Global Neurosurgery Market 2015-2019
  • Active Pharmaceutical Ingredients (API) Market in
    India 2015-2019
  • BrainStorm Cell Therapeutics Inc. (BCLI) -
    Financial and Strategic SWOT Analysis Review
  • Ampio Pharmaceuticals, Inc. (AMPE) - Financial
    and Strategic SWOT Analysis Review
  • MiMedx Group, Inc (MDXG) - Financial and
    Strategic SWOT Analysis Review

12
Related Reports
  • Threshold Pharmaceuticals, Inc. (THLD) -
    Financial and Strategic SWOT Analysis Review
  • MEI Pharma, Inc. (MEIP) - Financial and Strategic
    SWOT Analysis Review
  • Titan Pharmaceuticals, Inc. (TTNP) - Financial
    and Strategic SWOT Analysis Review
  • RedHill Biopharma Ltd. (RDHL) - Financial and
    Strategic SWOT Analysis Review
  • Pharmaceuticals Healthcare Market Research
    Reports

13
  • Myungmoon pharmaceutical Co.,Ltd. - Product
    Pipeline Review - 2014 Published Oct 2014 19
    Pages
  • Myungmoon pharmaceutical Co.,Ltd. - Product
    Pipeline Review - 2014report features
    investigational drugs from across globe covering
    over 20 therapy areas and nearly 3,000
    indications.
    Price

Format Price
PDF 1500
Site Licence 3000
Enterprise Wide Licence 4500
14
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog
  • http//www.aarkstore.com/blog/
  • Conference
  • http//conference.aarkstore.com/
  • News
  • http//www.aarkstore.com/news
About PowerShow.com